Lars Henning Engelholm

Lars Henning Engelholm

ORCID: 0000-0002-6616-1232

Publication year:
All
61 - 67 out of 67Page size: 10
  1. 2022
  2. Published

    Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment

    Fjæstad, K. Y., Rømer, A. M. A., Goitea, V., Johansen, A. Z., Thorseth, M. L., Carretta, M., Engelholm, Lars Henning, Grøntved, L., Junker, N. & Madsen, Daniel Hargbøl, 2022, In: Oncogene. 41, p. 1364-1375

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1

    Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Ingvarsen, S. Z., Heltberg, S. S., Hagensen, C. E., Gårdsvoll, Henrik, Madsen, D. H., Jensen, O. N., Engelholm, Lars Henning & Behrendt, Niels, 2022, In: Matrix Biology. 111, p. 307-328 22 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Uncovering mediators of collagen degradation in the tumor microenvironment

    Thorseth, M. L., Carretta, M., Jensen, C., Mølgaard, K., Jürgensen, Henrik Jessen, Engelholm, Lars Henning, Behrendt, Niels, Willumsen, N. & Madsen, Daniel Hargbøl, 2022, In: Matrix Biology Plus. 13, 100101.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Hypomorphic expression of parathyroid Bmal1 disrupts the internal parathyroid circadian clock and increases parathyroid cell proliferation in response to uremia

    Egstrand, S., Mace, M. L., Morevati, M., Nordholm, A., Engelholm, Lars Henning, Thomsen, J. S., Brüel, A., Naveh-Many, T., Guo, Y., Ølgaard, Klaus & Lewin, E., Jun 2022, In: Kidney International. 101, 6, p. 1232-1250 19 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2023
  7. Published

    A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

    Senkowski, W., Gall-Mas, L., Falco, M. M., Li, Y., Lavikka, K., Kriegbaum, M. C., Oikkonen, J., Bulanova, D., Pietras, E. J., Voßgröne, K., Chen, Y. J., Erkan, E. P., Dai, J., Lundgren, A., Grønning Høg, M. K., Larsen, I. M., Lamminen, T., Kaipio, K., Huvila, J., Virtanen, A. & 9 others, Engelholm, Lars Henning, Christiansen, P., Santoni Rugiu, Eric, Huhtinen, K., Carpén, O., Hynninen, J., Hautaniemi, S., Vähärautio, A. & Wennerberg, Krister, 2023, In: Developmental Cell. 58, 12, p. 1106-1121.e7 24 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Targeted delivery of alcohol-containing payloads with antibody-drug conjugates

    Grier, K. E., Hansen, A. H., Haxvig, C. S., Li, Xin, Krigslund, O., Behrendt, Niels, Engelholm, Lars Henning, Rossi, F., Sousa, B. C., Harradence, G. J., Camper, N. & Qvortrup, K. M., 2023, In: Chemical Communications. 59, 47, p. 7240-7242

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. 2024
  10. Published

    Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs

    Metrangolo, Virginia & Engelholm, Lars Henning, 2024, In: Cancers. 16, 2, 20 p., 447.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1...3 4 5 6 7 Next

ID: 9647887